Relationship of Phospholipid Transfer Protein Activity to HDL and Apolipoprotein B-Containing Lipoproteins in Subjects With and Without Type 1 Diabetes
- 1 November 2002
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 51 (11) , 3300-3305
- https://doi.org/10.2337/diabetes.51.11.3300
Abstract
Patients with type 1 diabetes have greatly increased phospholipid transfer protein (PLTP) activity and have an altered HDL subclass distribution. In 195 patients with type 1 diabetes and in 194 men and women aged 30–55 years, we examined the relationship of PLTP activity to HDL and examined whether PLTP activity contributes to differences in HDL found in type 1 diabetes. PLTP activity was measured using an exogenous substrate assay. Average HDL particle size and HDL subclasses were measured using nuclear magnetic resonance spectroscopy. Apolipoprotein AI (apoAI) and apoAII were measured by immunoturbidimetry. The amount of apoAI present in LpAI was measured using a differential electroimmunoassay, and the amount of apoAI in LpAIAII was inferred from the apoAI and LpAI data. Higher PLTP activity was associated with more large HDL (P < 0.001) and less small HDL (P < 0.01), more apoAI and apoAII (both at P < 0.001), and more apoAI in both LpAI and LpAIAII (P = 0.02 and P < 0.001, respectively). These associations were independent of other lipids and enzyme activities. Adjusting for PLTP activity halved the difference between subjects with and without diabetes in apoA1 (from 10.1 mg/dl higher in subjects with diabetes to 4.6 mg/dl higher) and large HDL (2.4 μmol/l higher to 1.2 μmol/l higher) and reduced the difference in HDL size (from 0.31 nm higher to 0.26 nm higher). PLTP activity was also positively associated with apoB, total VLDL and LDL particle number, and IDL level in subjects with diabetes. These data support the idea that PLTP is a major factor in HDL conversion and remodeling in humans and that higher PLTP activity makes an important contribution to the higher apoAI levels and altered HDL subclass distribution in type 1 diabetes. They also support a role for PLTP in the metabolism of apoB-containing lipoproteins.Keywords
This publication has 22 references indexed in Scilit:
- The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer ProteinJournal of Biological Chemistry, 2001
- Phospholipid Transfer Is a Prerequisite for PLTP-Mediated HDL ConversionBiochemistry, 2000
- Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetesEuropean Journal of Clinical Investigation, 1999
- Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levelsJournal of Clinical Investigation, 1999
- Mass Concentration of Plasma Phospholipid Transfer Protein in Normolipidemic, Type IIa Hyperlipidemic, Type IIb Hyperlipidemic, and Non–Insulin-Dependent Diabetic Subjects as Measured by a Specific ELISAArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen–progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal womenAtherosclerosis, 1997
- Opposite Effects of Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein on the Size Distribution of Plasma High Density LipoproteinsJournal of Biological Chemistry, 1996
- Regulation of apolipoprotein A-I-containing lipoproteins in IDDMDiabetes, 1993
- Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasmaAtherosclerosis, 1991
- Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transferAtherosclerosis, 1990